Herbal technology – challenges and opportunities for India – CSIR experience. P. Pushpangadan National Botanical Research Institute Rana Pratap Marg, Lucknow-226001. 21st Century.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Herbal technology – challenges and opportunities for India – CSIR experience
National Botanical Research Institute
Rana Pratap Marg, Lucknow-226001
21st century is the century of Biology powered and propelled by scientific knowledge and technological expertise
All technologies for the manufacture of value added plant products can be called as herbal technology
WORLD TRADE AND ECONOMIES: THE PARADIGM SHIFT
“A nation’s ability to convert knowledge in to wealth and social good through the process of innovation will determine its future” ( R A Mashelkar, 2001)
Global market of herbal drugs, Nutraceuticals ~$60 billion with 6% annual growth rate. Major share of Chinese and Koreans. Indian share variously estimated at 0.35-3.0%. Chinese production increased 200% between 1995-1999.
HERBAL DRUGS : RESURGENCE, OPPORTUNITY AND COMPETITION
THE USE OF PHYTOPHARMACEUTICALS IS INCREASING @ 15% AGAINST 3% FOR MODERN PHARMACEUTICALS.
THE NUMBER OF PEOPLE USING HERBAL PRODUCTS ROSE BY 50% LAST YEAR.
U. S. A.
35% OF OUT PATIENTS AND 22% OF INPATIENTS USE T.C.M. 940 HERBAL DRUG MANUFACTURING UNITS. HERBAL DRUG PRODUCTION ~ 18 BILLION CHINESE YUAN (DOMESTIC MARKETS). SALE OF HERBAL MEDICINE HAS 33% OF THE TOTAL DRUG MARKET.
60-70% POPULATION USE DRUGS OF INDIAN SYSTEM OF MEDICINES.
147 HERBAL MEDICINES ARE ELIGIBLE BY NATIONAL HEALTH INSURANCE SCHEME
DOES NOT DIFFERENTIATE BETWEEN PHARMACEUTICALS AND PHYTOPHARM -ACEUTICALS.
ANNUAL EXPENDITURE ON ALTERNATE MEDICINES AU $ 621 MILLION.
HERBAL MEDICINE OUTPUT OVER US $ 500 MILLION WHICH ACCOUNT FOR 12% OF THE TOTAL DRUG OUTPUT.
12% OF THE DAILY OUTPATIENTS VISIT T.M. PRACTITIONERS.
GLOBAL MEDICINAL PLANTS PRODUCT MARKET
NUTRACEUTICALS HERBAL DRUGS
US $ 250 BILLION US $ 12.4 BILLION
REGION% MARKET SHARE
REST OF EUROPE03
REST OF ASIA20
OTHER ASIAN PLANTS6.0%
LOCAL AND OTHER IMPORTS60.8%
% SHARES IN US HERBAL PRODUCT MARKET
REF P. Brevoort, 1997
GLOBAL SALE OF HERBAL DRUGS
(BILLION US $; RETAIL)
E. EUROPE0.370.400.03 8
REST OF WORLD0.20.30.130
WORLD PHYTOPHARMACEUTICAL MARKET
SOURCE : BUSINESS COMMUNICATION COMPANY INC.
SALE OF HERBAL MEDICINES IN DIFFERENT REGIONS OF THE WORLD
* EstimatesSource : IMS 1994; Gruenwald, 1997; Gruenwald, 2000
SOURCE: PHARMABIZ 2001
APPROPRIATE USE OF Herbal Drug
GUIDELINES – RATIONAL USE
Parameters required for quality evaluation of herbal drugs
Standardization & Quality Evaluation of Herbal drugs
QUALITY EVALUATION OF HERBAL DRUGS
HPTLC Finger printing Sec. Metabolites DNA Finger printing
HPTLC GLC HPLC
Vision of Herbal Drug Industry
“To provide intellectual capital to make available safe, cost effective, affordable therapeutics to the people of Indo-Pacific region – to help to reduce the percentage of mortality, morbidity and to emerge as significant players in the global market place.”
Problems faced by Indian Traditional Medicine
CSIR initiatives in Traditional Medicine